We pursue promising science to address some of the toughest challenges in autoimmune disease. Community guidelines: 1. By posting to our social media channels, or otherwise responding or commenting on our posts, you are agreeing to abide by these guidelines, which apply in addition to any terms and conditions or other notices or disclaimers that we may apply, or that may be applied by the host of the social media platform itself. 2. Unless posts are from an official Aurinia social media handle, none of the posts or comments are posts made by us, but from members of the public. We take no responsibility for comments or posts made by third parties on our channels, and the content of those comments or posts (including any opinions or statements) may not reflect our views, and are the responsibility of the individual posting them. 3. We may discuss medical and health-related topics on our social media feeds. The content we post, and any associated content shared by other users, should not be taken as medical advice. We ask that you refrain from soliciting or posting medical advice on this feed. For advice and information related to your health, please seek advice from your doctor or other healthcare professional. 4. Aurinia reserves the right to remove any content or comments that violate these guidelines or are otherwise deemed inappropriate. We may block or ban users who repeatedly violate these guidelines or engage in disruptive behavior. To learn more, visit: https://www.auriniapharma.com/aurinia-community-guidelines US-NA-2300266 08/23
View Top Employees from Aurinia Pharmaceuticals Inc.Website | http://www.auriniapharma.com/ |
Ticker | AUPH |
Revenue | $66.3 million |
Employees | 334 (334 on RocketReach) |
Founded | 2013 |
Phone | (250) 744-2487 |
Fax | (780) 484-4105 |
Technologies |
JavaScript,
HTML,
Twitter
+32 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Biopharma, Healthcare, Biotechnology, Health Care, Science and Engineering, Medical, Therapeutics |
Web Rank | 4 Million |
Keywords | Aurinia Pharmaceuticals, Voclosporin Ophthalmic Solution, Aurinia Pharmaceuticals Proxy Cirdular, Aurinia Royalty Board, Aurinia Pharmaceuticals Lupus Drug Mechanism |
Competitors | Altasciences, Fusion Pharmaceuticals, Turnstone Biologics, Xenon Pharmaceuticals Inc., Zymeworks Inc. |
SIC | SIC Code 28 Companies, SIC Code 2834 Companies, SIC Code 2835 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 54 Companies, NAICS Code 325 Companies, NAICS Code 541 Companies |
Looking for a particular Aurinia Pharmaceuticals Inc. employee's phone or email?
The Aurinia Pharmaceuticals Inc. annual revenue was $66.3 million in 2024.
Neil Solomons is the Chief Medical Officer and co-founder of Aurinia Pharmaceuticals Inc..
334 people are employed at Aurinia Pharmaceuticals Inc..
Aurinia Pharmaceuticals Inc. is based in Edmonton, Alberta.
The NAICS codes for Aurinia Pharmaceuticals Inc. are [32, 3254, 32541, 54, 325, 541].
The SIC codes for Aurinia Pharmaceuticals Inc. are [28, 2834, 2835, 283].